LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Mexican positioning statement for the preparticipation screening and cardiovascular evaluation in athletes.

    García-Saldivia, Marianna / Ilarraza-Lomelí, Hermes / Cossío-Aranda, Jorge E / Iturralde-Torres, Pedro / Guerra-López, Arturo / Avilés-Rosales, Jorge / Núñez-Urquiza, Juan P / Hernández-González, Pedro A / García-Hernández, Nayely / Cassaigne-Guasco, Ma Elena / Rodríguez-Díez, Gerardo / González-Gutiérrez, Jorge A / Rojel-Martínez, Ulises / Vallejo-Venegas, Enrique P / Jiménez-Santos, Moisés / Rojano-Castillo, Jessica / Crespo-Serje, Lady Liliana / Lara-Vargas, Jorge A / Ku-González, Andrés /
    Gaxiola-López, Efraín / Figueiras-Graillet, Lourdes / López-Cuéllar, Julio / Miranda-Malpica, Emma / Jordán-Ríos, Antonio

    Archivos de cardiologia de Mexico

    2023  Volume 93, Issue Supl 4, Page(s) 1–35

    Title translation Posicionamiento mexicano para el tamizaje y la evaluación cardiovascular preparticipación deportiva.
    MeSH term(s) Humans ; Athletes ; Mexico ; Cardiovascular Diseases/diagnosis ; Heart Disease Risk Factors
    Language English
    Publishing date 2023-12-26
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 2059019-2
    ISSN 1665-1731 ; 1665-1731
    ISSN (online) 1665-1731
    ISSN 1665-1731
    DOI 10.24875/ACM.M23000092
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Clinical practice guidelines for diagnostic and treatment of the chronic heart failure.

    Pavía-López, Abel A / Magaña-Serrano, José A / Cigarroa-López, José A / Chávez-Mendoza, Adolfo / Mayorga-Butrón, José L / Araiza-Garaygordobil, Diego / Ivey-Miranda, Juan B / Méndez-Machado, Gustavo F / González-Godínez, Héctor / Aguilera-Mora, Luisa F / Jordán-Ríos, Antonio / Olmos-Domínguez, Luis / Olalde-Román, Marcos J / Miranda-Malpica, Emma M / Vázquez-Ortiz, Zuilma / Rayo-Chávez, Jorge / Mendoza, Alexandra A / Márquez-Murillo, Manlio F / Chávez-Leal, Sergio A /
    Gabriel, Amada Álvarez-San / Silva-García, Marissa A / Pacheco-Bouthiller, Alex D / Aldrete-Velazco, Jorge A / Guizar-Sánchez, Carlos A / Gaxiola-López, Efraín / Guerra-López, Arturo / Figueiras-Graillet, Lourdes / Sánchez-Miranda, Gustavo / Mendoza-Zavala, Genaro H / Aceves-García, Moisés / Chávez-Negrete, Adolfo / Arroyo-Hernández, Marisol / Montaño-Velázquez, Bertha B / Romero-Moreno, Luis F / Baquero-Hoyos, María M / Velasco-Hidalgo, Liliana / Rodríguez-Lozano, Ana L / Aguilar-Gómez, Nancy E / Rodríguez-Vega, Mario / Cossío-Aranda, Jorge E

    Archivos de cardiologia de Mexico

    2024  Volume 94, Issue Supl 1, Page(s) 1–74

    Abstract: Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high ... ...

    Title translation Guía mexicana de práctica clínica para el diagnóstico y el tratamiento de la insuficiencia cardiaca.
    Abstract Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high prevalence of risk factors for developing heart failure, such as high blood pressure, diabetes, and obesity, which makes it essential to have an evidence-based document that provides recommendations to health professionals involved in the diagnosis and treatment of these patients. This document establishes the clinical practice guide (CPG) prepared at the initiative of the Mexican Society of Cardiology (SMC) in collaboration with the Iberic American Agency for the Development and Evaluation of Health Technologies, with the purpose of establishing recommendations based on the best available evidence and agreed upon by an interdisciplinary group of experts. This document complies with international quality standards, such as those described by the US Institute of Medicine (IOM), the National Institute of Clinical Excellence (NICE), the Intercollegiate Network for Scottish Guideline Development (SIGN) and the Guidelines International Network (G-I-N). The Guideline Development Group was integrated in a multi-collaborative and interdisciplinary manner with the support of methodologists with experience in systematic literature reviews and the development of CPG. A modified Delphi panel methodology was developed and conducted to achieve an adequate level of consensus in each of the recommendations contained in this CPG. We hope that this document contributes to better clinical decision making and becomes a reference point for clinicians who manage patients with chronic heart failure in all their clinical stages and in this way, we improve the quality of clinical care, improve their quality of life and reducing its complications.
    MeSH term(s) Humans ; Heart Failure/therapy ; Heart Failure/diagnosis ; Chronic Disease ; Mexico
    Language English
    Publishing date 2024-04-22
    Publishing country Mexico
    Document type Journal Article ; Practice Guideline
    ZDB-ID 2059019-2
    ISSN 1665-1731 ; 1665-1731
    ISSN (online) 1665-1731
    ISSN 1665-1731
    DOI 10.24875/ACM.M24000095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article: Progresos en el tratamiento del diabético con cardiopatía isquémica.

    Gaxiola-López, Efraín / Eng-Ceceña, Luis

    Archivos de cardiologia de Mexico

    2002  Volume 72 Suppl 1, Page(s) S69–75

    Abstract: Among the risk factors for ischemic cardiopathy none influences more long-term restenosis and mortality as diabetes mellitus. Diabetes mellitus is ranked third as cause of death; 65 to 85% of these patients die due to cardiovascular disease. The use of ... ...

    Title translation Progress in the treatment of diabetic patients with ischemic cardiopathy.
    Abstract Among the risk factors for ischemic cardiopathy none influences more long-term restenosis and mortality as diabetes mellitus. Diabetes mellitus is ranked third as cause of death; 65 to 85% of these patients die due to cardiovascular disease. The use of coronary stents associated to glycoprotein IIb/IIIa inhibitors has proven to be superior to stents alone or PTCA in the treatment of ischemic cardiopathy in diabetic patients. Despite these improved results, restenosis rates remain higher as compared to non-diabetic patients. Intracoronary radiation has been shown decrease restenosis and repeat target lesion revascularizations in diabetic patients with intra-stent restenosis. In order to decrease restenosis in diabetic patients, stents coated with site-specific pharmacological and molecular approaches may prove useful in suppressing hyperplasia of the intimal and preventing restenosis. Coronary artery bypass grafting seems to be the best option for diabetic patients with multiple coronary artery disease, especially if they have proximal left anterior descending artery estenosis, complex lesions to be approached by angioplasty, previous myocardial infarction, three vessel disease, or impaired left ventricular function. In spite of improvements in the treatment of diabetic patients with coronary artery disease, restenosis and mortality rates continue to be higher as compared to non-diabetic patients; therefore, new strategies are required.
    MeSH term(s) Coronary Restenosis ; Diabetes Complications ; Humans ; Myocardial Ischemia/etiology ; Myocardial Ischemia/therapy
    Language Spanish
    Publishing date 2002-01
    Publishing country Mexico
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 2047800-8
    ISSN 1405-9940
    ISSN 1405-9940
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.B 63: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top